Top Markets
#1 TENDIES TENDIES +42.31%
#2 Cash Cat Cash Cat +24.22%
#3 Asteroid Shiba Asteroid Shiba +16.17%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.93%
#6 Bluwhale Bluwhale +10.55%
#7 MarsCoin MarsCoin +8.17%
#8 Threshold Network Threshold Network +7.55%
#9 Pyth Network Pyth Network +7.25%
#10 Tornado Cash Tornado Cash +6.90%
Coin of the day
TENDIES TENDIES
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang in Aktien #16729
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Aktienkurs
$3.78
Zuletzt synchronisiert: 2026-03-17
Marktkapitalisierung
$276.54M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
45.53%
Land
CA
Handel NervGen Pharma Corp. (NGEN)

Kategorie

Healthcare
P/S-Verhältnis für NervGen Pharma Corp. (NGEN)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von NervGen Pharma Corp. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für NervGen Pharma Corp. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH